234 related articles for article (PubMed ID: 1663926)
1. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
Piddock LJ; Hall MC; Walters RN
J Antimicrob Chemother; 1991 Aug; 28(2):185-98. PubMed ID: 1663926
[TBL] [Abstract][Full Text] [Related]
2. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
[TBL] [Abstract][Full Text] [Related]
3. Quinolone resistance from a transferable plasmid.
Martínez-Martínez L; Pascual A; Jacoby GA
Lancet; 1998 Mar; 351(9105):797-9. PubMed ID: 9519952
[TBL] [Abstract][Full Text] [Related]
4. In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens.
Watanabe M; Kotera Y; Yosue K; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1990 Jan; 34(1):173-5. PubMed ID: 2183709
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.
Masecar BL; Robillard NJ
Antimicrob Agents Chemother; 1991 May; 35(5):898-902. PubMed ID: 1649573
[TBL] [Abstract][Full Text] [Related]
6. Characterization of quinolone resistance mechanisms in Enterobacteriaceae isolated from companion animals in Europe (ComPath II study).
de Jong A; Muggeo A; El Garch F; Moyaert H; de Champs C; Guillard T
Vet Microbiol; 2018 Mar; 216():159-167. PubMed ID: 29519511
[TBL] [Abstract][Full Text] [Related]
7. Broader distribution of plasmid-mediated quinolone resistance in the United States.
Robicsek A; Sahm DF; Strahilevitz J; Jacoby GA; Hooper DC
Antimicrob Agents Chemother; 2005 Jul; 49(7):3001-3. PubMed ID: 15980384
[TBL] [Abstract][Full Text] [Related]
8. Improved antimicrobial activity of DU-6859a, a new fluoroquinolone, against quinolone-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates with alterations in GyrA and ParC proteins.
Deguchi T; Yasuda M; KawamuraT ; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Kawada Y
Antimicrob Agents Chemother; 1997 Nov; 41(11):2544-6. PubMed ID: 9371364
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
Xu X; Wu S; Ye X; Liu Y; Shi W; Zhang Y; Wang M
Antimicrob Agents Chemother; 2007 Nov; 51(11):4105-10. PubMed ID: 17724159
[TBL] [Abstract][Full Text] [Related]
10. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae.
Weigel LM; Steward CD; Tenover FC
Antimicrob Agents Chemother; 1998 Oct; 42(10):2661-7. PubMed ID: 9756773
[TBL] [Abstract][Full Text] [Related]
11. Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
Sanders CC; Sanders WE; Goering RV; Werner V
Antimicrob Agents Chemother; 1984 Dec; 26(6):797-801. PubMed ID: 6098219
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises.
Thomson KS; Sanders CC; Hayden ME
Antimicrob Agents Chemother; 1991 Nov; 35(11):2329-34. PubMed ID: 1804005
[TBL] [Abstract][Full Text] [Related]
13. Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
Levy DD; Sharma B; Cebula TA
Antimicrob Agents Chemother; 2004 Jul; 48(7):2355-63. PubMed ID: 15215081
[TBL] [Abstract][Full Text] [Related]
14. Role of the outer membrane for quinolone resistance in enterobacteria.
Dechène M; Leying H; Cullmann W
Chemotherapy; 1990; 36(1):13-23. PubMed ID: 2106416
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae.
Ruiz J; Gómez J; Navia MM; Ribera A; Sierra JM; Marco F; Mensa J; Vila J
Diagn Microbiol Infect Dis; 2002 Apr; 42(4):257-61. PubMed ID: 12007443
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
[TBL] [Abstract][Full Text] [Related]
17. In-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, against clinical isolates of Klebsiella pneumoniae and Enterobacter cloacae with fluoroquinolone resistance-associated amino acid alterations in GyrA and ParC.
Deguchi T; Yasuda M; Kawamura T; Takahashi Y; Okezaki E; Nagata O; Kato H; Kawada Y
J Antimicrob Chemother; 1997 Dec; 40(6):907-9. PubMed ID: 9462448
[No Abstract] [Full Text] [Related]
18. Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992-98.
Robert J; Cambau E; Grenet K; Trystram D; Péan Y; Fiévet MH; Jarlier V
Clin Microbiol Infect; 2001 Oct; 7(10):553-61. PubMed ID: 11683796
[TBL] [Abstract][Full Text] [Related]
19. Characterization of high-level quinolone resistance in Campylobacter jejuni.
Gootz TD; Martin BA
Antimicrob Agents Chemother; 1991 May; 35(5):840-5. PubMed ID: 1649570
[TBL] [Abstract][Full Text] [Related]
20. High-level quinolone resistance amongst clinical isolates of Escherichia coli and Klebsiella pneumoniae from Spain.
Alarcón T; Pita J; López-Brea M; Piddock LJ
J Antimicrob Chemother; 1993 Oct; 32(4):605-9. PubMed ID: 8288502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
